Go offline with the Player FM app!
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology
Manage episode 398454707 series 2430750
Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.
Reach out and connect with both Imran and Junyun on social media platforms:
Imran House, Ph.D.
X: @ImranHouse
Junyun Lai, Ph.D.
X: @JunyunLai
44 episodes
Manage episode 398454707 series 2430750
Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.
Reach out and connect with both Imran and Junyun on social media platforms:
Imran House, Ph.D.
X: @ImranHouse
Junyun Lai, Ph.D.
X: @JunyunLai
44 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.